BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34331442)

  • 1. Pre-existing Thyroiditis Ameliorates Papillary Thyroid Cancer: Insights From a New Mouse Model.
    Pani F; Yasuda Y; Di Dalmazi G; Chalan P; Gabrielson K; Adamo L; Sabini E; Mariotti S; Caturegli P
    Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34331442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.
    Kim SJ; Myong JP; Jee HG; Chai YJ; Choi JY; Min HS; Lee KE; Youn YK
    Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
    Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential relationship between Hashimoto's thyroiditis and BRAF(V600E) mutation status in papillary thyroid cancer.
    Zeng RC; Jin LP; Chen ED; Dong SY; Cai YF; Huang GL; Li Q; Jin C; Zhang XH; Wang OC
    Head Neck; 2016 Apr; 38 Suppl 1():E1019-25. PubMed ID: 26041461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological characterization and prognostic implication of FOXP3 and CK19 expression in papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis.
    Mohamed SY; Ibrahim TR; Elbasateeny SS; Abdelaziz LA; Farouk S; Yassin MA; Embaby A
    Sci Rep; 2020 Jun; 10(1):10651. PubMed ID: 32606302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound, laboratory and histopathological insights in diagnosing papillary thyroid carcinoma in a paediatric population: a single centre follow-up study between 2000-2022.
    Januś D; Wójcik M; Taczanowska-Niemczuk A; Kiszka-Wiłkojć A; Kujdowicz M; Czogała M; Górecki W; Starzyk JB
    Front Endocrinol (Lausanne); 2023; 14():1170971. PubMed ID: 37274328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warthin-like papillary thyroid carcinoma with immunoglobulin G4-positive plasma cells possibly related to Hashimoto's thyroiditis.
    Hirokawa M; Nishihara E; Takada N; Higuchi M; Kotakemori M; Hayashi T; Miyauchi A
    Endocr J; 2018 Feb; 65(2):175-180. PubMed ID: 29093307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating BRAF
    Zhang Z; Zhang X; Yin Y; Zhao S; Wang K; Shang M; Chen B; Wu X
    BMC Cancer; 2022 Apr; 22(1):461. PubMed ID: 35473554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of hashimoto thyroiditis in papillary thyroid cancer patients and its impact on their Outcome.
    Batool S; Das B; Arif M; Islam N
    J Ayub Med Coll Abbottabad; 2022; 34(2):251-255. PubMed ID: 35576281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Liu Y; Lv H; Zhang S; Shi B; Sun Y
    Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis.
    Kim WW; Ha TK; Bae SK
    J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):4. PubMed ID: 29316976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.
    Lubin D; Baraban E; Lisby A; Jalali-Farahani S; Zhang P; Livolsi V
    Endocr Pathol; 2018 Dec; 29(4):317-323. PubMed ID: 30121940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hashimoto's thyroiditis on outcomes in papillary thyroid cancer revisited: experience from South East Asia.
    Lau J; Lee J; Mahipal M; Yang SP; Tan WB; Yuan NK; Parameswaran R
    Ann R Coll Surg Engl; 2022 Jun; 104(6):465-471. PubMed ID: 34982591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
    Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
    Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary squamous cell carcinoma of the thyroid associated with papillary thyroid carcinoma and Hashimoto's thyroiditis.
    Kallel S; Kallel R; Ayadi S; Ghorbel A
    Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Aug; 135(4):291-293. PubMed ID: 29914738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound evolution of parenchymal changes in the thyroid gland with autoimmune thyroiditis in children prior to the development of papillary thyroid carcinoma - a follow-up study.
    Januś D; Kujdowicz M; Wójcik M; Taczanowska-Niemczuk A; Kiszka-Wiłkojć A; Górecki W; Starzyk JB
    Front Endocrinol (Lausanne); 2023; 14():1172823. PubMed ID: 37124746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of lncRNA-mediated ceRNA regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto's thyroiditis.
    Zhang Y; Tian Y
    BMC Endocr Disord; 2022 Oct; 22(1):252. PubMed ID: 36266640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present.
    Marotta V; Guerra A; Zatelli MC; Uberti ED; Di Stasi V; Faggiano A; Colao A; Vitale M
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):733-8. PubMed ID: 23469895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis.
    Subhi O; Schulten HJ; Bagatian N; Al-Dayini R; Karim S; Bakhashab S; Alotibi R; Al-Ahmadi A; Ata M; Elaimi A; Al-Muhayawi S; Mansouri M; Al-Ghamdi K; Hamour OA; Jamal A; Al-Maghrabi J; Al-Qahtani MH
    PLoS One; 2020; 15(6):e0234566. PubMed ID: 32603365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.
    Stanciu AE; Serdarevic N; Hurduc AE; Stanciu MM
    Scand J Clin Lab Invest; 2015 Nov; 75(7):539-48. PubMed ID: 26305420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.